Published in Physiol Behav on December 01, 2002
Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A (2005) 3.12
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) (2003) 1.86
DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci U S A (2003) 1.71
GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast (2011) 1.51
Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr Opin Neurobiol (2011) 1.35
Circuits formultisensory integration and attentional modulation through the prefrontal cortex and the thalamic reticular nucleus in primates. Rev Neurosci (2007) 1.24
Spatial and temporal bias in the mitotic origins of somatostatin- and parvalbumin-expressing interneuron subgroups and the chandelier subtype in the medial ganglionic eminence. Cereb Cortex (2011) 1.16
Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats. Biol Psychiatry (2009) 1.05
Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology (Berl) (2006) 1.03
Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci (2010) 0.99
Anterior cingulate synapses in prefrontal areas 10 and 46 suggest differential influence in cognitive control. J Neurosci (2010) 0.98
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology (2010) 0.96
The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention. Psychopharmacology (Berl) (2012) 0.96
Preferential accumulation of GABAA receptor gamma 2L, not gamma 2S, cytoplasmic loops at rat spinal cord inhibitory synapses. J Physiol (2004) 0.95
Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience (2010) 0.93
Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology (2010) 0.91
Perineuronal nets and schizophrenia: the importance of neuronal coatings. Neurosci Biobehav Rev (2014) 0.90
Age-related changes in rostral basal forebrain cholinergic and GABAergic projection neurons: relationship with spatial impairment. Neurobiol Aging (2012) 0.88
Polysialic acid is required for dopamine D2 receptor-mediated plasticity involving inhibitory circuits of the rat medial prefrontal cortex. PLoS One (2011) 0.86
Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring. Transl Psychiatry (2014) 0.85
Phencyclidine/schizophrenia: one view toward the past, the other to the future. Schizophr Bull (2012) 0.85
Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia? J Neural Transm (Vienna) (2007) 0.84
A quantitative system pharmacology computer model for cognitive deficits in schizophrenia. CPT Pharmacometrics Syst Pharmacol (2013) 0.83
Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases. Neuroscience (2012) 0.83
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. Curr Neuropharmacol (2005) 0.83
How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia. Antioxid Redox Signal (2012) 0.82
Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence? Front Psychiatry (2013) 0.82
GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes. PLoS One (2013) 0.82
Prefrontal cortical GABA transmission modulates discrimination and latent inhibition of conditioned fear: relevance for schizophrenia. Neuropsychopharmacology (2014) 0.81
Specialized prefrontal "auditory fields": organization of primate prefrontal-temporal pathways. Front Neurosci (2014) 0.81
Prefrontal cortical GABAergic signaling and impaired behavioral flexibility in aged F344 rats. Neuroscience (2016) 0.80
Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation. BMC Neurosci (2008) 0.79
Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction. Neuropsychopharmacology (2013) 0.79
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology. Front Pharmacol (2015) 0.78
Fos expression in the brains of rats performing an attentional set-shifting task. Neuroscience (2010) 0.78
Tandospirone, a 5-HT1A partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia. Front Behav Neurosci (2014) 0.78
Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration. Neuropsychopharmacology (2016) 0.77
Vulnerability of synapses in the frontal cortex of mice developmentally exposed to an insecticide: Potential contribution to neuropsychiatric disease. Neurotransmitter (Houst) (2015) 0.77
Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration. Front Hum Neurosci (2015) 0.76
Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam. Int J Neuropsychopharmacol (2016) 0.75
Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine. Neuropsychopharmacology (2015) 0.75
Preliminary Study on Quantitative Sleep EEG Characteristics in Patients with Schizophrenia. Psychiatry Investig (2017) 0.75
Neurophysiology and Regulation of the Balance Between Excitation and Inhibition in Neocortical Circuits. Biol Psychiatry (2016) 0.75
Genetic disruption of ankyrin-G in adult mouse forebrain causes cortical synapse alteration and behavior reminiscent of bipolar disorder. Proc Natl Acad Sci U S A (2017) 0.75
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci (2008) 8.14
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci (2003) 4.86
The future of psychiatry as clinical neuroscience. Acad Med (2009) 3.31
Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. J Low Genit Tract Dis (2015) 3.30
Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry (2008) 3.16
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol (2006) 2.93
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull (2008) 2.81
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis (2008) 2.76
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry (2014) 2.46
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
Conflict of interest. Am J Psychiatry (2006) 2.30
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci (2005) 2.18
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology (2008) 1.93
Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry (2011) 1.91
Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep (2010) 1.87
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One (2013) 1.83
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex (2002) 1.77
Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet (2002) 1.68
Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66
Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry (2002) 1.65
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry (2008) 1.64
Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex (2008) 1.61
Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2005) 1.61
Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol Psychiatry (2009) 1.58
Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry (2007) 1.57
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull (2012) 1.57
Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology (2002) 1.55
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52
The generic enhancement of photochromic dye switching speeds in a rigid polymer matrix. Nat Mater (2005) 1.52
GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast (2011) 1.51
A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci (2008) 1.51
Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother (2010) 1.48
Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biol Psychiatry (2006) 1.47
Conflict of interest, round 2. Am J Psychiatry (2006) 1.44
Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry (2014) 1.44
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. Biol Psychiatry (2004) 1.43
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. Biol Psychiatry (2012) 1.43
Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry (2012) 1.40
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation. J Neurosci (2007) 1.35
Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. J Neurophysiol (2004) 1.35
Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry (2006) 1.34
Mapping auditory core, lateral belt, and parabelt cortices in the human superior temporal gyrus. J Comp Neurol (2005) 1.34
Interneuron diversity in layers 2-3 of monkey prefrontal cortex. Cereb Cortex (2008) 1.33
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32
Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci (2011) 1.30
Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry (2010) 1.30
Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb Cortex (2010) 1.30
Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol (2003) 1.29
Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.28
Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb Cortex (2007) 1.27
Cluster analysis-based physiological classification and morphological properties of inhibitory neurons in layers 2-3 of monkey dorsolateral prefrontal cortex. J Neurophysiol (2005) 1.23
Cortical basket cell dysfunction in schizophrenia. J Physiol (2012) 1.22
Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol Psychiatry (2011) 1.22
Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology (2004) 1.21
Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci (2010) 1.20
Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20
Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull (2011) 1.20
Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2009) 1.18
Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb Cortex (2006) 1.17
Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology (2011) 1.15
Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J Comp Neurol (2002) 1.15
Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol Psychiatry (2010) 1.14
Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis (2011) 1.13
Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. Arch Gen Psychiatry (2010) 1.11
Characterization of a novel β-lactamase-producing plasmid in Neisseria gonorrhoeae: sequence analysis and molecular typing of host gonococci. J Antimicrob Chemother (2011) 1.10
Atypical antipsychotic medications and the treatment of schizophrenia. Am J Psychiatry (2002) 1.10
Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area. Synapse (2004) 1.08
Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa. Sex Transm Dis (2014) 1.08
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis (2009) 1.08
Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. Cereb Cortex (2011) 1.07
Cortical opioid markers in schizophrenia and across postnatal development. Cereb Cortex (2011) 1.06
Platform influence on DNA microarray data in postmortem brain research. Neurobiol Dis (2005) 1.05
Integration of preventing mother-to-child transmission of HIV and syphilis testing and treatment in antenatal care services in the Northern Cape and Gauteng provinces, South Africa. Sex Transm Dis (2013) 1.05
Primary visual cortex volume and total neuron number are reduced in schizophrenia. J Comp Neurol (2007) 1.05
Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res (2002) 1.03
Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology (2005) 1.03
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology (2008) 1.03
Molecular markers distinguishing supragranular and infragranular layers in the human prefrontal cortex. Eur J Neurosci (2007) 1.02
Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice. Neurobiol Dis (2005) 1.02
SERT-ainly involved in depression, but when? Am J Psychiatry (2006) 1.01
Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia. Neuropsychopharmacology (2009) 1.01
Etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa. Sex Transm Dis (2010) 1.01
Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry (2006) 1.00
Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons. J Physiol (2007) 1.00
Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. J Comp Neurol (2004) 1.00
GABA transporter GAT1 prevents spillover at proximal and distal GABA synapses onto primate prefrontal cortex neurons. J Neurophysiol (2008) 0.99
Identification of predominant culturable vaginal Lactobacillus species and associated bacteriophages from women with and without vaginal discharge syndrome in South Africa. J Med Microbiol (2010) 0.99
An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections. Brain Res (2008) 0.99
Parvalbumin-containing chandelier and basket cell boutons have distinctive modes of maturation in monkey prefrontal cortex. J Neurosci (2013) 0.98
Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. Am J Psychiatry (2014) 0.97